Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors

BACKGROUND: Vast amounts of rapidly accumulating biological data related to cancer and a remarkable progress in the field of artificial intelligence (AI) have paved the way for precision oncology. Our recent contribution to this area of research is CancerOmicsNet, an AI-based system to predict the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Singha, Manali, Pu, Limeng, Stanfield, Brent A., Uche, Ifeanyi K., Rider, Paul J. F., Kousoulas, Konstantin G., Ramanujam, J., Brylinski, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694576/
https://www.ncbi.nlm.nih.gov/pubmed/36434556
http://dx.doi.org/10.1186/s12885-022-10293-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694576/
https://www.ncbi.nlm.nih.gov/pubmed/36434556
http://dx.doi.org/10.1186/s12885-022-10293-0

Ejemplares similares